The Division of General Surgery, under the leadership of Dr. William E. Fisher., is bringing a new array of specialty care to Baylor St. Luke’s Medical Center at the same time it is introducing closed-unit critical care and acute care surgery services campus-wide. Equally important are the tremendous strides the division has made in the past 18 months integrating its clinical services and research programs across our campus, with cross-institutional faculty appointments, universal clinical care protocols, and campus-wide research databases. These unprecedented efforts set the stage for optimized patient care and a research powerhouse representing Baylor surgical care.
Baylor College of Medicine offers one of the best general surgery residency programs in the country. This five-year program accepts eight categorical first-year residents and graduates eight chief residents each year.
The Baylor College of Medicine surgical critical care residency is a one-year program that accepts three residents annually. The program provides residents with a training in all phases of surgical critical care, research, and intensive care unit management.
At Ben Taub Hospital—our surgeons see nearly 13,000 cases in the Ben Taub Emergency Trauma Center annually. This iconic center serves approximately one million of the under-served in Houston, nearly a quarter of the entire population of Harris County.
At the Michael E. DeBakey VA Medical Center the primary healthcare provider for almost 130,000 veterans in Southeast Texas— a team of faculty surgeons have helped raise MEDVAMC to the rank of the most advanced of the Veterans Affairs’ 141 medical facilities in terms of clinical care, research, and trainee education.
At Baylor St. Luke’s Medical Center and at four other affiliated institutions, division surgeons perform procedures ranging from complex bariatric surgery to robotic abdominal operations.
As a result of the general surgery division’s innovative research programs, patients receive specialized diagnostic assessment; access to the newest treatment modalities, including clinical trials of new pharmacologic therapies and emerging surgical techniques; and coordinated follow-up of their care at all of our clinical sites.